Patient Benefit Index (PBI) in the treatment of Psoriasis - Results of the National Care Study "PsoHealth"

European Journal of Dermatology

Volumn 23, Issue 2, 2013, Pages 212-217

  Radtke, Marc Alexander ^a   Schäfer, Ines ^a   Blome, Christine ^a   Augustin, Matthias ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Care; Outcome research; Patient benefit; Patient Benefit Index; Pso health; Psoriasis; Quality of life

Indexed keywords

CALCINEURIN INHIBITOR; COLECALCIFEROL DERIVATIVE; DITHRANOL; EMOLLIENT AGENT; METHOXSALEN; STEROID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; FEMALE; GUTTATE PSORIASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT BENEFIT INDEX; PATIENT CARE; PATIENT PREFERENCE; PATIENT SATISFACTION; PHYSIOTHERAPY; PREVALENCE; PSORIASIS; PSORIASIS SEVERITY INDEX; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; PUSTULAR PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE;

CARE; OUTCOME RESEARCH; PATIENT BENEFIT; PATIENT BENEFIT INDEX; PSOHEALTH; PSORIASIS; QUALITY OF LIFE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL THERAPY; CROSS-SECTIONAL STUDIES; DERMATOLOGIC AGENTS; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PSORIASIS; PUVA THERAPY; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84877774754     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2013.1988     Document Type: Article

References (37)

1. Schäfer I, Rustenbach SJ, Radtke M, Augustin J, Glaeske G, Augustin M. Epidemiology of Psoriasis in Germany - Analysis of Secondary Health Insurance Data. Gesundheitswesen. Gesundheitswesen 2011; 73: 308-311.
2. Schaefer I, Rustenbach SJ, Zimmer L, Augustin M. Prevalence of skin diseases in a cohort of 48.665 employees in Germany. Dermatology 2008; 217: 169-172.
3. Reich K, Krüger K, Mössner R, Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 2009; 160: 1040-1047.
4. Radtke MA, Reich K, Blome C, Rustenbach S, Augustin M. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey. J Eur Acad Dermatol Venereol 2009; 23: 683-691.
5. Sterry W, Strober BE, Menter A, & on behalf of the International Psoriasis Council. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol 2007; 157: 649-655.
6. Setty AR, Urhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses'Health Study II. Arch Intern Med 2007; 167: 1670-1675.
7. Augustin M, Reich K, Glaeske G, Schaefer I, Radtke M. Comorbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany. Acta Derm Venereol 2010; 90: 147-151.
8. Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schäfer I. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol 2010; 162: 633-636.
9. Augustin M, Krüger K, Radtke MA, Schwippl I, Reich K. Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany. Dermatology 2008; 216: 366-372.
10. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001; 7: 280-284.
11. Dubertret L, Mrowietz U, Ranki A, et al.; EUROPSO Patient Survey Group. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 2006; 155: 729-736
12. Reich K, Mrowietz U. Treatment goals in psoriasis. J Dtsch Dermatol Ges 2007; 5: 566-574.
13. Price J, Bhosle M, Feldman SR, Balkrishnan R. Outcomes associated with the use of biologic agents in moderate to severe psoriasis. J Drugs Dermatol 2007; 6: 259-267.
14. Menter A, Griffiths CE. Current and future management of psoriasis. Lancet 2007; 370: 272-284.
15. Morsy H, Kamp S, Jemec GB. Outcomes in randomized controlled trials in psoriasis: What has changed over the last 20 years? J Dermatol Treat 2007; 18: 261-267.
16. Augustin M, Reich K, Radtke MA. Lebensqualität, Compliance und Empowerment bei Psoriasis. 1. Auflage - Bremen: UNI-MED, 2007.
17. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999; 47(6): 555-567.
18. Zentner A, Velasco-Garrido M, Busse R (2005) Methoden zur vergleichenden Bewertung pharmazeutischer Produkte. GMS Health Technol Assess (Internet). 2005 Nov 15 (cited 2009 Aug 19);1:Doc09 (20051115). Available from: http://www.egms.de/dynamic/en/journals/hta/volume1.htm
19. Augustin M, Radtke MA, Zschocke I, et al. The patient benefit index: a novel approach in patient-defined outcomes measurement for skin dieases. Arch Dermatol Res 2009; 301: 561-571.
20. Augustin M, Zschocke I, Lange S, Seidenglanz K, Amon U. Quality of life in skin diseases: methodological and practical comparison of different quality of life questionnaires in psoriasis and atopic dermatitis. Hautarzt 1999; 50: 715-722.
21. Augustin M, Amon U, Braathen L, et al. Assessment of quality of life in dermatology. J Dtsch Dermatol Ges 2004; 9: 802-806.
22. Puzenat E, Bronsard V, Prey S, et al. What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature. J Eur Acad Dermatol Venereol 2010; 24: 10-16.
23. Frederiksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244.
24. Finaly AY. Current severe psoriasis and the rule of tens. Br J Dermatol 2005; 152: 861-867.
25. Mrowietz U, Kragballe K, Reich K, et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 2011; 303: 1-10.
26. Nast A, Boehncke WH, Mrowietz U, et al. S3-guidelines for the treatment of psoriasis vulgaris Update 2011. J Dtsch Dermatol Ges. 2011; 9(Suppl 2): S1-S104.
27. Augustin M, Reich K, Reich C, et al. Quality of psoriasis care in Germany-results of the national study PsoHealth 2007. J Dtsch Dermatol Ges 2008; 6: 640-645.
28. Radtke MA, Reich K, Blome C, et al. Evaluation of quality of care and guideline-compliant treatment in psoriasis. Development of a new system of quality indicators. Dermatology 2009; 219: 54-58.
29. Fredriksson T, Pettersson U. Oral treatment of pustulosis palmo-plantaris with a new retinoid, Ro10-9359. Dermatologica 1979; 158: 60-64.
30. Augustin M, Reich C, Schaefer I, Zschocke I, Rustenbach SJ. Development and validation of a new instrument for the assessment of patient-defined benefit in the treatment of acne. J Dtsch Dermatol Ges 2008; 6: 1-8.
31. Augustin M, Gajur AI, Reich C, Rustenbach SJ, Schaefer I. Benefit Evaluation in Vitiligo Treatment: Development and Validation of a Patient-Defined Outcome Questionnaire. Dermatology 2008; 217: 101-106.
32. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
33. M Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997; 36: 551-559.
34. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622-629.
35. Feuerhahn J, Blome C, Radtke M, Augustin M. Validation of the patient benefit index for the assessment of patient-relevant benefit in the treatment of psoriasis. Arch Dermatol Res 2012 [Epub ahead of print].
36. Blome C, Augustin M, Behechtnejad J, Rustenbach SJ. Dimensions of Patient Needs in Dermatology: Subscales of the Patient Benefit Index. Arch Dermatol Res 2011; 303: 11-17.
37. Garduno J, Bhosle MJ, Balkrishnan R, Feldman SR. Measures used in specifying psoriasis lesion(s), global disease and quality of life: a systematic review. J Dermatolog Treat 2007; 18: 223-242.